Literature DB >> 7718319

Psychological reactions in patients with malignant melanoma.

Y Brandberg1, E Månsson-Brahme, U Ringborg, P O Sjödén.   

Abstract

Psychological and psychosomatic reactions to malignant melanoma were studied, comparing patients with tumour thickness < or = 0.8 mm versus > 0.8 mm and recurrent versus non-recurrent patients. Gender differences were also studied. Consecutive melanoma patients, Stage I (n = 144), were interviewed at their first postsurgery follow-up visit to an oncology clinic and completed questionnaires 7 and 13 months later. The questionnaire contained items regarding interest in nevi, sleeping problems, psychosomatic complaints, and the Hospital Anxiety and Depression Scale. Patients with a more unfavourable prognosis (tumour thickness > 0.8 mm), subjected to regular medical procedures, did not differ from those with a more favourable prognosis (< or = 0.8 mm), except reporting more sleeping problems. Women had considerably higher levels of problems than men. Amongst patients with an unfavourable prognosis, those with recurrence within 2 years showed lower levels of anxiety at the first visit compared with those free from recurrence after 2 years.

Entities:  

Mesh:

Year:  1995        PMID: 7718319     DOI: 10.1016/0959-8049(94)00333-z

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Criterion-based validation of the EORTC QLQ-C36 in advanced melanoma: the CIPS questionnaire and proxy raters.

Authors:  V Sigurdardóttir; Y Brandberg; M Sullivan
Journal:  Qual Life Res       Date:  1996-06       Impact factor: 4.147

2.  Screening for Predictive Parameters Requiring Psycho-Oncological Intervention via the National Comprehensive Cancer Network Distress Thermometer in the Follow-Up of Uveal Melanoma Patients.

Authors:  Annemarie Klingenstein; Christina Samel; Aylin Garip-Kuebler; Siegfried G Priglinger; Paul I Foerster
Journal:  Clin Ophthalmol       Date:  2020-11-09

3.  Quality of life in the follow-up of uveal melanoma patients after enucleation in comparison to CyberKnife treatment.

Authors:  A Klingenstein; C Fürweger; A K Mühlhofer; S F Leicht; U C Schaller; A Muacevic; B Wowra; C Hintschich; K H Eibl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-16       Impact factor: 3.117

Review 4.  A Global Review of Melanoma Follow-up Guidelines.

Authors:  Shannon C Trotter; Novie Sroa; Richard R Winkelmann; Thomas Olencki; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

5.  Stress-induced Norepinephrine Downregulates CCL2 in Macrophages to Suppress Tumor Growth in a Model of Malignant Melanoma.

Authors:  Kayla J Steinberger; Michael T Bailey; Amy C Gross; Laura A Sumner; Jeffrey L Voorhees; Nisha Crouser; Jennifer M Curry; Yijie Wang; A Courtney DeVries; Clay B Marsh; Ronald Glaser; Eric V Yang; Timothy D Eubank
Journal:  Cancer Prev Res (Phila)       Date:  2020-06-09

6.  A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients.

Authors:  E Hammerlid; M Ahlner-Elmqvist; K Bjordal; A Biörklund; J Evensen; M Boysen; M Jannert; S Kaasa; M Sullivan; T Westin
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

Review 7.  Immunotherapy in the management of melanoma: current status.

Authors:  Dylan Alston; Jerry D Brewer
Journal:  Immunotargets Ther       Date:  2013-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.